Learn More
BACKGROUND The past decade, medical technology assessment focused on cost-effectiveness analysis, yet there is an increasing need to consider equity implications of health interventions as well. This(More)
• Across Europe, the clinical and economic burden of advanced non-small cell lung cancer (aNSCLC) is high. • Approximately 20% of cancer mortality in European men and women is due to lung cancer; the(More)
BACKGROUND Economic evaluation of stroke services indicates that such services may lead to improved quality of life at affordable cost. The present study assesses lifetime health impact and cost(More)